Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized phase 3 trial of lomustine addition in older adults with acute myeloid leukemia
2007-003803-11Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lomustine in acute myeloid leukemia (AML) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Overall survival and Complete remission rate. Started Aug 2007; status: active.
02
Drugs
lomustine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2007-003803-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003803-11.